Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:31:04.495Z.
Calculation as of: 2026-10-06T13:31:04.495Z.
Quote observation: 2026-10-06T13:30:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea268c636d02c1563f9a0cc17fa45ef3048b6802d4031696aa30e1bc9d7aaf2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Connect Biopharma Holdings Limited
Market Cap
$55.80M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $55.80M | N/A |
| Aldeyra The (ALDX)vs › | $57.31M | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $58.88M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.71M | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.84M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.89M | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.33M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
